Description
Tesamorelin is a synthetic peptide analog of human growth hormone-releasing hormone, also known as growth hormone-releasing factor. It has been investigated for its interaction with GHRH receptors and its effects on pituitary signaling, endogenous growth hormone secretion, and related metabolic pathways.
Research Applications
- Growth Hormone-Releasing Hormone Receptor Studies
- Pituitary Signaling Research
- Endogenous Growth Hormone Secretion Studies
- IGF-1 Pathway Investigation
- Metabolic and Adipose-Tissue Research
- Peptide-Receptor Interaction Analysis
Scientific Background
Tesamorelin is a stabilized analog of the naturally occurring 44-amino-acid growth hormone-releasing hormone peptide. It interacts with GHRH receptors on pituitary somatotroph cells, stimulating the synthesis and pulsatile release of endogenous growth hormone. This activity can subsequently influence IGF-1 and other growth hormone-related signaling pathways.
Researchers continue to examine Tesamorelin’s receptor-binding properties, molecular stability, endocrine signaling activity, and effects within controlled laboratory and clinical research models.
Specifications
Compound: Tesamorelin
Category: Synthetic Research Peptide
Classification: GHRH/GRF Analog
Form: Lyophilized Powder
Purity: See Current COA
Use: Research and Analytical Applications
Research Use Only
This product is supplied exclusively for laboratory research and analytical purposes. It is not intended for human consumption, self-administration, diagnostic use, veterinary use, or therapeutic application. It should be handled only by qualified professionals in an appropriate laboratory or research environment.

Reviews
There are no reviews yet.